Tag: Pharmaceutical

AstraZeneca
Untied Kingdom

AstraZeneca to invest $2.5 billion in new global strategic R&D centre, biotech agreements and manufacturing in Beijing

AstraZeneca is establishing a new global strategic R&D centre in Beijing, its second in China and sixth worldwide Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai Press Release – 21 March 2025 – AstraZeneca today announced an investment of $2.5 billion in Beijing to establish its sixth global strategic R&D centre together with major research and manufacturing agreements that will further advance … Continue reading AstraZeneca to invest $2.5 billion in new global strategic R&D centre, biotech agreements and manufacturing in Beijing

Impact Newswire
Atomwise Appoints Steve Worland, Ph.D. as Chief Executive Officer
United States

Atomwise Appoints Steve Worland, Ph.D. as Chief Executive Officer

Proven Pharmaceutical Executive Brings Over 30 Years of R&D Experience to Supercharge the Company’s Next Phase of Growth Seasoned Biotechnology Leader Mike Varney, Ph. D., Appointed as Lead Independent Director of the Board Press Release – SAN FRANCISCO, CALIFORNIA, FEBRUARY 18, 2025 – Atomwise, a leader in leveraging machine learning and artificial intelligence (ML/AI) to advance small molecule drug discovery, today announced the appointment of Steve … Continue reading Atomwise Appoints Steve Worland, Ph.D. as Chief Executive Officer

Impact Newswire
Jean-Charles Wirth
Europe

New CEOs for Life Science and Healthcare business sectors and New Chief People Officer

The Board of Partners of E. Merck KG has appointed three new members to the Executive Board of Merck KGaA. Press Release – 18 Feb 2025 | Darmstadt, Germany Darmstadt, Germany, February 18, 2025 – The Board of Partners of E. Merck KG has appointed three new members to the Executive Board of Merck KGaA – a natural evolution in the company’s leadership as it continues to … Continue reading New CEOs for Life Science and Healthcare business sectors and New Chief People Officer

Impact Newswire
Wedgewood Appoints Stanley Howell as Chief Operations Officer
United States

Wedgewood Appoints Stanley Howell as Chief Operations Officer to Drive Growth and Operational Excellence

Press Release – February 06, 2025 – SWEDESBORO, N.J. – Wedgewood, the nation’s largest provider of compounded veterinary medications and pharmacy solutions, has appointed Stanley Howell as Chief Operations Officer. Howell brings extensive expertise in operations, strategy, and supply chain excellence, reinforcing Wedgewood’s commitment to innovation, efficiency, and best-in-class service for veterinary professionals. Howell’s appointment comes at a pivotal time as Wedgewood builds upon the momentum from VMX … Continue reading Wedgewood Appoints Stanley Howell as Chief Operations Officer to Drive Growth and Operational Excellence

Impact Newswire
AstraZeneca
Untied Kingdom

AstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery

Press Release – 23 January 2025 700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies AstraZeneca, a global pharmaceutical company focused on developing life changing medicines, today announced a C$820 million (US$570m) investment in Canada, creating more than 700 high-skilled jobs, across all areas of the business. The investment will support … Continue reading AstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery

Impact Newswire
sanofi
Europe

Opella reaches study milestone for Cialis

Press Release – Paris, January 21, 2025. Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its planned actual use trial (AUT) to support the switch of Cialis (tadalafil) from a prescription to an over-the-counter medicine. This decision allows for the initiation of the AUT and makes Cialis the first PDE-5 inhibitor to achieve … Continue reading Opella reaches study milestone for Cialis

Impact Newswire
servier
Europe

Servier appoints David K. Lee to Executive Committee

Press Release – 13 January 2025 – Suresnes (France), January 13th, 2025 – Servier, an independent international pharmaceutical group, announces the appointment of David K. Lee to its Executive Committee as Executive Vice President for the United States, effective January 1, 2025. David K. Lee has held the position of Chief Executive Officer (CEO) of Servier Pharmaceuticals in the United States since the creation of … Continue reading Servier appoints David K. Lee to Executive Committee

Impact Newswire
hovione
Europe

Hovione strengthens its global position as a top employer for the third consecutive year

Hovione has once again solidified its position as a top employer. Press Release – Jan 16, 2025 Lisbon, January 16, 2025 – Hovione, an international integrated pharmaceutical development and manufacturing organization, has once again solidified its position as a top employer. For the third consecutive year, all four of its manufacturing sites – Lisbon (Portugal), Cork (Ireland), East Windsor (NJ, USA), and Macau – have been … Continue reading Hovione strengthens its global position as a top employer for the third consecutive year

Impact Newswire
IDRx
Untied Kingdom

GSK Enters Agreement to Acquire IDRx, Inc.

Press Release – January 13, 2025 – PLYMOUTH, Mass. – GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based, clinical-stage biopharmaceutical company dedicated to developing precision therapeutics for the treatment of GIST. Under the agreement, GSK will pay $1 billion upfront, with potential for an additional $150 million success-based … Continue reading GSK Enters Agreement to Acquire IDRx, Inc.

Impact Newswire